首页 | 本学科首页   官方微博 | 高级检索  
检索        

巨噬细胞移动抑制因子和细胞周期蛋白D1的表达与肝细胞癌生长和转移的关系
引用本文:夏金堂,李雯,刘云建,陈连周,伍兆峰,张珑涓,汪谦.巨噬细胞移动抑制因子和细胞周期蛋白D1的表达与肝细胞癌生长和转移的关系[J].中华肝脏病杂志,2007,15(12):918-921.
作者姓名:夏金堂  李雯  刘云建  陈连周  伍兆峰  张珑涓  汪谦
作者单位:1. 广州医学院附属广州市第一人民医院肝胆外科,510180
2. 中山大学附属第一医院外科实验中心
基金项目:广东省自然科学基金(5001776);广州市科技计划项目(200523-E0381)
摘    要:目的研究巨噬细胞移动抑制因子(MIF)、细胞周期蛋白D1(Cyclin D1)、细胞周期蛋白依赖激酶4(CDK4)、磷酸化视网膜母细胞瘤易感基因产物蛋白(phospho—Rb)在HeC组织中的表达及其与癌细胞生长和转移的关系。方法应用组织芯片技术和免疫组织化学方法检测93份HCC组织中MIF、Cyclin D1、CDK4和phospho—Rb的表达,分析它们的表达与HCC临床病理特征的关系。结果93份HCC组织中MIF、Cyclin D1、CDK4和phospho—Rb的表达率分别为71%、41%、82%和14%,MIF和Cyclin D1阳性表达率与正常肝脏组织表达率之间的差异有统计学意义(P〈0.01),CDK4和phospho—Rb阳性表达率与正常肝脏组织表达率之间的差异无统计学意义(P〉0.05)。在≥3.5cm的肿瘤中MIF表达率为79%,明显高于在〈3.5cm肿瘤中的表达率48%(P〈0.01);有转移的肝癌组织中Cyclin D1阳性率为62%,明显高于无转移组织中的阳性率35%,差异有统计学意义(P〈0.05)。MIF表达强弱与Cyclin D1的表达呈正相关关系(P〈0,01)。CDK4和phospho—Rb的表达与肿瘤大小及是否转移的关系无统计学意义。结论MIF和Cyclin D1在HCC发展进程中可能促进肿瘤的生长和转移。

关 键 词:  肝细胞  巨噬细胞游走抑制因子  细胞周期蛋白D1  免疫组织化学
收稿时间:2007-05-28

Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma
XIA Jin-tang,LI Wen,LIU Yun-jian,CHEN Lian-zhou,WU Zhao-feng,ZHANG Long-juan,WANG Qian.Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma[J].Chinese Journal of Hepatology,2007,15(12):918-921.
Authors:XIA Jin-tang  LI Wen  LIU Yun-jian  CHEN Lian-zhou  WU Zhao-feng  ZHANG Long-juan  WANG Qian
Institution:Department of Hepatobiliary Surgery, First Municipal Hospital of Guangzhou, Guangzhou Medical College, Guangzhou, China.
Abstract:OBJECTIVE: To explore the possible relationship between the expressions of macrophage migration inhibitor factor (MIF), cyclin D1, cyclin-dependent kinase 4 (CDK4), phosphorylated-retinoblastoma susceptibility gene product Rb protein (phospho-Rb) and the development of hepatocellular carcinoma (HCC). METHODS: 93 HCC tissues and 5 normal liver tissues were used to investigate the expressions of MIF, cyclin D1, CDK4 and phospho-Rb by tissue microarray and immunohistochemistry methods. RESULTS: The expression rates of MIF, cyclin D1, CDK4 and phospho-Rb in the HCC tissues were 71%, 41%, 82% and 14% respectively, and in the normal liver tissues, they were 0%, 0%, 80% and 20% respectively. The expression rates of MIF and cyclin D1 were significantly different between the tumor and the normal liver tissues and the expression rates of CDK4 and phospho-Rb were not significantly different between the tumor and the normal liver tissues. The rate difference (69% versus 48%) of MIF expression between the larger tumors (> 3.5 cm) and the smaller tumors (< 3.5 cm) was of statistical significance (P < 0.01). The expression rate (62%) of cyclin D1 in the tumors with metastasis was significantly higher than the expression rate (35%) in the tumors without metastasis (P < 0.05). MIF expression was positively correlated with cyclin D1 expression in the tumor tissues (P < 0.01). CDK4 and phospho-Rb expressions were not significantly associated with the tumor sizes and metastasis status. CONCLUSION: Our results indicate that MIF and cyclin D1 might be related to the growth and metastasis of HCC.
Keywords:Carcinoma  hepatocellular  Macrophage migration-inhibitor factors  Cyclin D1  Immunohistochemistry
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号